However, more plausible explanations include de novo developments from normal lung epithelium to KRAS- or BRAF-mutated invasive adenocarcinomas as a result of KRAS or BRAF mutations and additional genomic changes, including genomic instability caused by defective DNA repair or smoking (Figure 4) [79,80]. This evidence concerns the gene BRAF and adenocarcinoma.